InnoCan Pharma Corporation (INNO.CN)
CAD 0.18
(0.0%)
CAD 0.18
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11 Thousand USD | -2.94% |
| 2022 | 34 Thousand USD | 3300.0% |
| 2021 | 1000.00 USD | -97.37% |
| 2020 | 38 Thousand USD | -47.22% |
| 2019 | 72 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 7000.00 USD | -36.36% |
| 2024 Q2 | 4000.00 USD | -42.86% |
| 2023 Q2 | 26 Thousand USD | 0.0% |
| 2023 Q4 | 11 Thousand USD | -31.25% |
| 2023 Q1 | 26 Thousand USD | -23.53% |
| 2023 FY | 11 Thousand USD | -67.65% |
| 2023 Q3 | 16 Thousand USD | -38.46% |
| 2022 Q3 | 25 Thousand USD | 108.33% |
| 2022 FY | 34 Thousand USD | 3300.0% |
| 2022 Q1 | 14 Thousand USD | 1300.0% |
| 2022 Q4 | 34 Thousand USD | 36.0% |
| 2022 Q2 | 12 Thousand USD | -14.29% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 1000.00 USD | -97.37% |
| 2021 Q4 | 1000.00 USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 Q2 | 20 Thousand USD | -33.33% |
| 2020 Q1 | 30 Thousand USD | -58.33% |
| 2020 FY | 38 Thousand USD | -47.22% |
| 2020 Q4 | 38 Thousand USD | 280.0% |
| 2020 Q3 | 10 Thousand USD | -50.0% |
| 2019 Q4 | 72 Thousand USD | 63.64% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 72 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q3 | 44 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.47 Thousand CAD | 98.669% |
| Ayurcann Holdings Corp. | 709.07 Thousand CAD | 98.449% |
| Blueberries Medical Corp. | 12.8 Thousand CAD | 14.089% |
| The BC Bud Corporation | 229.35 Thousand CAD | 95.204% |
| BioNxt Solutions Inc. | 4.89 Million CAD | 99.775% |
| CordovaCann Corp. | 6.37 Million CAD | 99.828% |
| Christina Lake Cannabis Corp. | 6.09 Million CAD | 99.82% |
| Captor Capital Corp. | 6.71 Million CAD | 99.836% |
| City View Green Holdings Inc. | 1.49 Million CAD | 99.266% |
| 1CM Inc. | 6.39 Million CAD | 99.828% |
| Global Hemp Group Inc. | 3.55 Million CAD | 99.691% |
| Greenway Greenhouse Cannabis Corporation | 16.02 Million CAD | 99.931% |
| IM Cannabis Corp. | 13.78 Million CAD | 99.92% |
| Lobe Sciences Ltd. | 332.64 Thousand CAD | 96.693% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 99.556% |
| Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
| Nextleaf Solutions Ltd. | 449.74 Thousand CAD | 97.554% |
| Ovation Science Inc. | 192.61 Thousand CAD | 94.289% |
| Pharmadrug Inc. | 1.76 Million CAD | 99.377% |
| Captiva Verde Wellness Corp. | 191.7 Thousand CAD | 94.262% |
| RAMM Pharma Corp. | 405.14 Thousand CAD | 97.285% |
| RIV Capital Inc. | 6.59 Million CAD | 99.833% |
| Revive Therapeutics Ltd. | 25.21 Thousand CAD | 56.377% |
| Red White & Bloom Brands Inc. | 262.13 Million CAD | 99.996% |
| SLANG Worldwide Inc. | 29.86 Million CAD | 99.963% |
| 1933 Industries Inc. | 17.57 Million CAD | 99.937% |
| Red Light Holland Corp. | 811.04 Thousand CAD | 98.644% |
| Top Strike Resources Corp. | 13.29 Million CAD | 99.917% |
| Xebra Brands Ltd. | - CAD | -Infinity% |
| Adastra Holdings Ltd. | 3.58 Million CAD | 99.693% |